These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17230000)

  • 1. [Role of bile acids on Barrett's esophagus].
    Kazumori H; Kinoshita Y
    Nihon Shokakibyo Gakkai Zasshi; 2007 Jan; 104(1):10-6. PubMed ID: 17230000
    [No Abstract]   [Full Text] [Related]  

  • 2. The pathogenesis of Barrett's esophagus: secondary bile acids upregulate intestinal differentiation factor CDX2 expression in esophageal cells.
    Hu Y; Williams VA; Gellersen O; Jones C; Watson TJ; Peters JH
    J Gastrointest Surg; 2007 Jul; 11(7):827-34. PubMed ID: 17458588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acids but not acidic acids induce Barrett's esophagus.
    Sun D; Wang X; Gai Z; Song X; Jia X; Tian H
    Int J Clin Exp Pathol; 2015; 8(2):1384-92. PubMed ID: 25973022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging concepts of bile reflux in the constellation of gastroesophageal reflux disease.
    Kauer WK; Stein HJ
    J Gastrointest Surg; 2010 Feb; 14 Suppl 1():S9-16. PubMed ID: 19756880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis of Barrett esophagus: deoxycholic acid up-regulates goblet-specific gene MUC2 in concert with CDX2 in human esophageal cells.
    Hu Y; Jones C; Gellersen O; Williams VA; Watson TJ; Peters JH
    Arch Surg; 2007 Jun; 142(6):540-4; discussion 544-5. PubMed ID: 17576890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of Barrett's esophagus and adenocarcinoma.
    Dvorak K; Goldman A; Kong J; Lynch JP; Hutchinson L; Houghton JM; Chen H; Chen X; Krishnadath KK; Westra WM
    Ann N Y Acad Sci; 2011 Sep; 1232():381-91. PubMed ID: 21950830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Barrett's Esophagus, fundoplication, and cancer.
    Watson DI; Mayne GC; Hussey DJ
    World J Surg; 2007 Mar; 31(3):447-9. PubMed ID: 17334863
    [No Abstract]   [Full Text] [Related]  

  • 8. From Reflux Esophagitis to Esophageal Adenocarcinoma.
    Souza RF
    Dig Dis; 2016; 34(5):483-90. PubMed ID: 27331918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acids induce Delta-like 1 expression via Cdx2-dependent pathway in the development of Barrett's esophagus.
    Tamagawa Y; Ishimura N; Uno G; Aimi M; Oshima N; Yuki T; Sato S; Ishihara S; Kinoshita Y
    Lab Invest; 2016 Mar; 96(3):325-37. PubMed ID: 26568294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrett's esophagus.
    Demeester SR; Peters JH; Demeester TR
    Curr Probl Surg; 2001 Aug; 38(8):558-640. PubMed ID: 11468640
    [No Abstract]   [Full Text] [Related]  

  • 11. Acid, bile, and CDX: the ABCs of making Barrett's metaplasia.
    Souza RF; Krishnan K; Spechler SJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Aug; 295(2):G211-8. PubMed ID: 18556417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.
    Schlottmann F; Molena D; Patti MG
    Updates Surg; 2018 Sep; 70(3):339-342. PubMed ID: 30039277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current challenges in Barrett's esophagus.
    Falk GW
    Cleve Clin J Med; 2001 May; 68(5):415-7, 422-4. PubMed ID: 11352321
    [No Abstract]   [Full Text] [Related]  

  • 14. Reflux, Barrett's, and adenocarcinoma of the esophagus: can we disrupt the pathway?
    DeMeester SR
    J Gastrointest Surg; 2010 Jun; 14(6):941-5. PubMed ID: 20094815
    [No Abstract]   [Full Text] [Related]  

  • 15. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus.
    Dai JY; de Dieu Tapsoba J; Buas MF; Onstad LE; Levine DM; Risch HA; Chow WH; Bernstein L; Ye W; Lagergren J; Bird NC; Corley DA; Shaheen NJ; Wu AH; Reid BJ; Hardie LJ; Whiteman DC; Vaughan TL
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1739-47. PubMed ID: 26377193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis of Barrett's metaplasia and the progression to esophageal adenocarcinoma.
    Grotenhuis BA; van Lanschot JJ; Dinjens WN; Wijnhoven BP
    Recent Results Cancer Res; 2010; 182():39-63. PubMed ID: 20676870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COX-2 induction by unconjugated bile acids involves reactive oxygen species-mediated signalling pathways in Barrett's oesophagus and oesophageal adenocarcinoma.
    Song S; Guha S; Liu K; Buttar NS; Bresalier RS
    Gut; 2007 Nov; 56(11):1512-21. PubMed ID: 17604323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barrett's esophagus: what do we really know about this disease?
    Fennerty MB
    Am J Gastroenterol; 1997 Jan; 92(1):1-3. PubMed ID: 8995929
    [No Abstract]   [Full Text] [Related]  

  • 19. Bile acids induce overexpression of homeobox gene CDX-2 and vascular endothelial growth factor (VEGF) in human Barrett's esophageal mucosa and adenocarcinoma cell line.
    Burnat G; Rau T; Elshimi E; Hahn EG; Konturek PC
    Scand J Gastroenterol; 2007 Dec; 42(12):1460-5. PubMed ID: 17852856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia.
    McQuaid KR; Laine L; Fennerty MB; Souza R; Spechler SJ
    Aliment Pharmacol Ther; 2011 Jul; 34(2):146-65. PubMed ID: 21615439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.